Elis stock breaks through its €22.60 resistance and climbs 2.5% after Q3

Q3 up 6.1% and 2026 targets confirmed by management

The Elis stock advances 2.71% to €22.74, in a CAC 40 that gains 1.11%. The stock rebounds following revenue of €1,323.9 million in the third quarter, published on October 28, up 6.1% on a reported basis and 3.5% on an organic basis.

Organic growth is accelerating quarter-over-quarter, following 3.1% in the first quarter and 3.2% in the second. The group confirms all of its 2026 targets in turn, with growth notably supported by the rollout of contracts signed in the first half in Europe.

Latin America's organic growth is slowing due to the situation in Mexico. From a stock market perspective, today's gains extend a 4% gain over seven days, although the stock is still down nearly 12% over three months.

Meanwhile, CIC Market Solutions maintained its buy rating with a price target of €29, representing potential upside of approximately 29% from the current price, as shown by the analyst consensus.

Stock breaks through €22.60 resistance and exceeds its 50-day moving average

In the same move, the stock broke through its 30-day high of €22.60 during the session and is holding above it, at €22.72 at the latest reading. This level, a former resistance, now acts as support.

The price is trading above the 20-day moving average at €21.84 (+4.12%) and the 50-day moving average at €22.52 (+0.98%). The 200-day moving average at €25.08 remains 9.33% above the current price, illustrating the ground to be made up after this quarter's decline.

The RSI at 58 remains neutral. On the market side, net declared short positions have fallen to 1.24% of capital, split between two funds, compared to 4.51% thirty days ago. This decline of 3.27 percentage points signals a significant easing of bearish bets on the stock.

Elis has also repurchased €604 million in shares over twelve months, representing 11.1% of its market capitalization. Next technical level: resistance at €28.22.